These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6848628)

  • 1. Procompetition legislation: the moral dilemmas of untested assumptions.
    Pellegrino ED
    J Fam Pract; 1983 Jan; 16(1):17-9. PubMed ID: 6848628
    [No Abstract]   [Full Text] [Related]  

  • 2. The antitrust swamp: how can healthcare professionals avoid it?
    Weller CD
    Healthc Financ Manage; 1982 Oct; 36(10):26-8, 30-6. PubMed ID: 10315211
    [No Abstract]   [Full Text] [Related]  

  • 3. The sleeping giant awakens: the physician and the antitrust laws.
    Hirsh HL
    Leg Med; 1985; ():334-56. PubMed ID: 3835424
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitrust in health care.
    Boland JM
    Colo Med; 1982 Mar; 79(3):116-8. PubMed ID: 6896026
    [No Abstract]   [Full Text] [Related]  

  • 5. Reconciling the antitrust laws and the health care laws: a step backward?
    Berg RN
    J Med Assoc Ga; 1981 Aug; 70(8):577-9. PubMed ID: 7276770
    [No Abstract]   [Full Text] [Related]  

  • 6. Competition in health insurance markets.
    Pauly MV
    Law Contemp Probl; 1988; 51(2):237-71. PubMed ID: 10295964
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitrust and the new competition in health care: excerpts.
    Ginsburg DH
    Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent cases cloud price-setting issue for managed care.
    Proger PA; Miles JJ
    Contract Healthc; 1988 Oct; ():30-1. PubMed ID: 10291187
    [No Abstract]   [Full Text] [Related]  

  • 9. The third party is now the first party.
    DeWeese BM
    J Ky Med Assoc; 1989 Jun; 87(6):265-6. PubMed ID: 2738451
    [No Abstract]   [Full Text] [Related]  

  • 10. Reagan administration disappoints competition advocates, opponents.
    Simler SL
    Mod Healthc; 1981 Nov; 11(11):114-5. PubMed ID: 10253230
    [No Abstract]   [Full Text] [Related]  

  • 11. Is competition the answer?
    Cost Containment; 1981 Sep; 3(18):3-6. PubMed ID: 10252981
    [No Abstract]   [Full Text] [Related]  

  • 12. Committee holds hearings on competition proposals.
    Champlin L
    Med Prod Sales; 1981 Dec; 12(12):1, 30, 32-3. PubMed ID: 10253914
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative delivery systems are focus of antitrust scrutiny.
    Scammon DL; Fuller DA; Sheffet MJ
    J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715
    [No Abstract]   [Full Text] [Related]  

  • 14. Provider-sponsored ADSs: reducing antitrust liability after Maricopa.
    Walsh JH; Feller H
    Spec Law Dig Health Care (Mon); 1985 Apr; 7(2):5-25. PubMed ID: 10270877
    [No Abstract]   [Full Text] [Related]  

  • 15. Legal issues loom for PPOs.
    Snyder JD; Bale C
    Physicians Manage; 1983 Jul; 23(7):69-70, 75-6, 79. PubMed ID: 10262982
    [No Abstract]   [Full Text] [Related]  

  • 16. Two PPOs get good reviews from Justice.
    Lefton D
    Am Med News; 1983 Oct; 26(37):1, 29. PubMed ID: 10263078
    [No Abstract]   [Full Text] [Related]  

  • 17. Most-favored-nation clauses and monopsonistic power: an unhealthy mix?
    Stenger SE
    Am J Law Med; 1989; 15(1):111-28. PubMed ID: 2764011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives. PPOs face antitrust problems.
    Wash Rep Med Health; 1984 Nov; 38(44):suppl 4p. PubMed ID: 10268861
    [No Abstract]   [Full Text] [Related]  

  • 19. FTC strives for high profile in health care related reform efforts.
    Cronin C
    Bus Health; 1987 Jun; 4(8):55. PubMed ID: 10282050
    [No Abstract]   [Full Text] [Related]  

  • 20. PPOs: a challenge to HMOs?
    Kendrick M
    Group Health J; 1985; 6(2):22-7. PubMed ID: 10274981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.